PER3 VNTR variant and susceptibility to smoking status/substance use disorder in a Turkish population by Nursal, Ayse Feyda et al.
Original article
PER3 VNTR variant and susceptibility to smoking status/substance 













1 Department of Medical Genetics, Hitit University, Faculty of Medicine, Corum, Turkey.
2 Department of Psychiatry, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Istanbul, Turkey. 
3 University of Health Sciences, Yedikule Hospital for Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey.
4 Department of Haematology, Gaziantep University, Faculty of Medicine, Gaziantep, Turkey.
5 Department of Medical Biology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
Received: 05/15/2019 – Accepted: 09/15/2019
DOI: 10.1590/0101-60830000000235
Abstract
Background: Substance use and smoking exert devastating impact on sleep, especially hindering the ease of falling asleep, compromising the sleep maintenance, 
and distorting the sleep cycles. PERIOD genes are believed to play a role in individual differences in sleep timing by influencing circadian. Objective: The aim 
of this study was to ascertain whether Per3 VNTR variant affects suspectibility of individuals to substance use disorder (SUD) and smoking status in a Turkish 
population. Methods: A total of 549 subjects, including 212 SUD patients, 160 smoker, and 177 healthy controls, matched by ethnicity, age, and gender, were 
recruited in a case-control study. Genotyping of Per3 variant was performed using PCR method. Results: When the SUD, smoker groups and controls were 
compared in terms of 5R/5R, 5R/4R, 4R/4R genotypes, no significant difference was observed. Besides, allele frequencies of Per3 VNTR were similar among the 
groups. Discussion: Our data indicate that Per3 VNTR variant is not associated with the risk of SUD and smoking status in our population. 
Nursal AF et al. / Arch Clin Psychiatry. 2020;47(3):71-4
Keywords: Substance use disorder, smoking status, Per3, VNTR, PCR.
Address for correspondence: Ayse Feyda Nursal. Department of Medical Genetics, Faculty of Medicine, Hitit University, Corum, Turkey. Telephone: 0 364 2221100. Fax: 0 364 2221102. 
E-mail: feyda.nursal@gmail.com
Introduction
The term substance use disorders (SUDs) refers numerous disorders, 
such as alcohol abuse, alcoholism, drug abuse and drug addiction. 
These disorders affect myriad of adults and families, cost medical, 
economic, criminal, and social sectors of society more than 500 billion 
dollars, and result in more than 75,000 deaths in the U.S.1. SUDs can 
occur in any individual, but the risk can be higher depending on an 
individual’s biological predisposition (e.g., genetic vulnerability), 
environment, and developmental stage (e.g., adolescence). Tobacco 
use increases the risk of major health problems and is the main cause 
of morbidity and mortality. The relation between cigarette smoking 
and many health issues, such as cardiovascular disease, pulmonary 
disorders, and cancer, is well known. Studies have demonstrated a 
clear association between poor sleep pattern and a number of adverse 
health behaviors, such as tobacco use, alcohol consumption, illicit 
drug use, suicide attempts, and unintentional injury2.
Human diurnal preference is a well-established circadian 
phenotype with regard to the preferred timing of daily activities3. 
Circadian rhythms are modulated by various canonical clock genes 
that are extremely conserved in all species, with allelic variants 
affecting individual rhythms at different levels4. The circadian 
rhythm is controlled by these clock genes. Period homolog 3 (Per3) 
or Clock homologue (CLOCK), have been investigated as potential 
genetic correlates of chronotypes and other circadian phenotypes in 
humans5. A variable-number tandem repeat (VNTR) polymorphism 
(rs57875989) in the Per3 gene (located on chromosome 1p36.23), 
containing two alleles of 4 or 5 tandem 54 bp repeats (coding for a 
region of 18 amino acids in exon 18), has been assessed as a possible 
genetic factor for chronotypes and other circadian phenotypes6. 
Some research show that circadian gene variants might modify the 
function of these genes, hence modifying diurnal preference and 
sleep-wake patterns7.
Because sleeping impairments are seen more frequently in this 
disorders, we aimed to ascertain whether Per3 VNTR variant affects 
susceptibility of individuals to substance use disorder (SUD) and 
smoking status in a Turkish population 
Methods
Study population
This case-control association study included 212 patients with SUD, 
160 smokers, and 177 healthy controls. The subjects with SUD were 
selected from among the individuals with positive urine test in the 
Department of Psychiatry, Bakirkoy Research and Training Hospital 
for Psychiatry Hospital, Istanbul Turkey. All SUD patients in the study 
met DSM-IV (American Psychiatry Association) criteria8. Smoker 
group was selected from the Department of Chest Diseases, Yedikule 
Hospital for Chest Diseases and Thoracic Surgery Training and 
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Research Hospital, Istanbul, Turkey. Smoker group consisted of active 
smokers. These subjects were defined as those who had previously 
smoked more than one cigarette per day but had quit smoking for 
more than one year. The degree of smoking was evaluated by the 
scores on the Fagerström Test for Nicotine Dependence (FTND)9. 
Control group was recruited from “non-smokers” were defined as 
those who had smoked less than one cigarette per day for no more 
than 1 year during their lifetime and subjects who did not have 
a personal history of any psychiatric disorder and chronic use of 
any drugs. All subjects were of Turkish origin. Before enrollment, 
signed informed consent was obtained from each participant. The 
study protocols were performed according to the principles of the 
Declaration of Helsinki. This study was approved by the Ethics 
Committees of the Istanbul University, Istanbul Medical Faculty.
Genotyping
Peripheral blood was taken from subjects, and DNA was isolated 
using a standard salting out method10. Polymerase chain reaction 
(PCR) was performed to amplify the exon 18 using the primers: 
upstream, 5’-CCTTGGTTGACCACAGGTAA-3’ and downstream, 
5’-CCACTACCTGATGCTGCTGA-3’ (amplification conditions: 
95 oC for 30 seconds, 60 oC for 30 seconds, 72 oC for 45 seconds, recycle 
for 28 cycles, 72 oC for 10 min, 48C forever), and in 40 ml mixture 
containing 3.2 mL (2.5 mM) deoxyribonucleotide triphosphate, 3.2 
mL (25 mM) Mg+2, 0.4 mL (5 U/mL) Taq polymerase, 4 mL 10_ 
buffer; 25.4 mL H2O, 1 mL of each primer (10 mM) and 1.8 mL (50 
ng/mL) DNA template. Three percent agarose gel electrophoresis 
was used to identify whether individuals were heterozygous or 
homozygous for either of the Per3 repeat alleles. 
Statistical analysis
The genotype distribution and allele frequency of the Per3 VNTR 
variant in the control and patient groups were compared using Chi-
square test. The Hardy-Weinberg equilibrium (HWE) was calculated 
using the de Finetti program (Online HWE and Association Testing-
Institut für Humangenetik, Munich, Germany). Odds ratio (OR) 
and 95% confidence intervals (CIs) were estimated using the binary 
logistic regression method. p values less than p < 0.05 were considered 
statistically significant.
Results
Allelic and genotypic distributions of the Per3 VNTR variant in 
subjects and controls are shown in Table 1. Among the 212 SUD 
patients, 16.6% were identified with the 5R/5R genotype, 45.7% with 
the 5R/4R genotype and 37.7% with the 4R/4R genotype; among the 
160 smoker subjects, 20% were identified with the 5R/5R genotype, 
38.2% with the 5R/4R genotype and 41.8% with the 4R/4R genotype; 
among the 177 control subjects, 15.8% were identified with the 5R/5R 
genotype, 43.6% with the 5R/4R genotype and 40.6% with the 4R/4R 
genotype. The genotype distribution of Per3 VNTR variant did not 
show any statistically significant differences between subjects with 
SUD, smokers and controls (p > 0.05). Also, allele frequencies of 
Per3 VNTR were similar between the groups. The observed genotype 
counts deviated significantly from those expected in smoker group 
according to the HWE for Per3 VNTR variant.
Discussion
Circadian rhythms are universal in all living organisms and almost all 
physiological functions, most remarkably sleep and wake cycles, show 
circadian rhythmicity. Circadian rhythms occur intrinsically and 
remain in the lack of environmental time cues. The suprachiasmatic 
nucleus (SCN), a structure located in the anterior hypothalamus is the 
region of a master circadian clock11. Essentially every physiological 
and behavioral parameter follows the nearly 24-hour (circadian) 
rhythms, the sleep/wake cycle being the most evident. Sleep is a 
dynamic and complex set of physiological conditions that plays a 
fundamental role in life. Sleep is characterized by a alignment of 
central nervous system characteristics, such as an unequalled profile 
of brain-wave activity, eye movements, and muscle activity12. 
The chronic abuse of substances may arise due to a desire to 
relieve negative affect, including anxiety or depressed mood, to 
palliate physical pain, to improve sleep, or to increase experience 
of pleasure. After dependence has developed, withdrawal from 
the substance can result in many unpleasant consequences. One 
of the most common results of the use of and withdrawal from 
substances of abuse is sleep disturbance. It has been reported that 
sleep disturbances occur in up to 90% of alcoholic individuals13. 
The correlation between substance use and sleep problems seems 
to be bidirectional14 with sleep problems enhancing risk for SUDs15, 
and acute and chronic substance use causing acute and chronic 
sleep problems16. Most studies in this area are based on surveys 
and demonstrate that smokers subjectively report sleep problems17. 
Investigating large populations of smokers, a subjectively decreased 
quality of sleep and more insomnia-like symptoms (decreased sleep 
quality, longer time for sleep onset, less restorative sleep; compared 
with non-smokers have been found18,19. These impairments are 
ascribed the stimulating effect of nicotine20,21. 
The circadian rhythm is subject to coordinated modulation 
of clock genes including Arntl, Dbp and Csnk1d, and the period 
homologs Per1, Per2 and Per322. One of the main parts of the 
endogenous clock system is gene Per3 that is periodically transcribed 
contributing to generate 24-h cycles of physiological and metabolic 
processes in certain cells. The Per3 gene from the protein PERIOD 
family has a pleiotropic effect on the cell clock mechanism, 
particularly in the modulation of sleep homeostasis and chronotype 
preferences6. The principal role of Per3 involves regulating sleep/wake 
timing and sleep homeostasis23. 
Table 1. Genotypes and alleles distribution of Per3 VNTR variant in cases and controls
Per3 VNTR SUD  group Smoker group Control group OR* %95 CI* P
Genotypes n: 212 (%) n: 160 (%) n: 177 (%)

































HWEp 0.543 0.011 0.333
*Pearson chi-square test; a: SUD group versus control group; b: Smoker group versus control; HWE: Hardy-Weinberg equilibrium. The results that are statistically significant are shown in boldface.
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The most investigated variant in Per3 gene is a biallelic VNTR 
polymorphism in a region encoding an assumed phosphorylation 
site24. In humans, this primate-specific polymorphism consists of a 
54-nucleotide unit that is repeated 4 (Per 4 allele) or 5 (Per 5 allele) 
times25. The longer, 5-repeat allele has been related with enhanced 
morning preference, higher sleep propensity and poorer cognitive 
performance in response to sleep deprivation, while the 4-repeat 
allele is related with eveningness. Individuals with the Per3 5/5 
genotype displayed an extreme diurnal preference-earlier wake-up 
and sleep-times26. Per3 VNTR has been associated with multiple 
phenotypic parameters, such as diurnal preference, myocardial 
infarction, sleep disturbances in multiple sclerosis, mood disorders, 
and also with an increased breast cancer risk6,25,27-29. 
While the PERIOD family could be considered as possible 
modulators of sleep function, we focused on the gene for Per3 VNTR 
variant and SUD/smoking status and we aimed to clarify the impact 
of the Per3 VNTR variant on susceptibility SUD and smoking status 
in a Turkish population. This is the first study carried out in the 
Turkish population regarding the association Per3 VNTR variant 
and SUD/smoking status. Some studies have proposed the role 
of Per2 in alcohol consumption behavior in humans and animal 
models. Spanagel et al. showed that a SNP in Per2 (rs56013859) 
was associated with high levels of alcohol use in alcohol dependent 
patients30. Gamsby et al. reported that mutation of either Per1 or 
Per2, as well as mutations of both genes, increases ethanol intake 
and reinforcement in an ethanol-preferring mouse model31. Malison 
et al. found that there was no link between CLOCK, Per1 or Per2 
variants and susceptibility to cocaine addiction32. In another study, 
it was reported that Per2 VNTR variant was significantly associated 
with vulnerability to cocaine addiction33. Brower et al. evaluated that 
the association Per3 genotype and insomnia severity in subjects with 
alcohol dependence34. They found that the subjects with the Per3 
(4/4) genotype had the greatest severity of insomnia symptoms. 
In this study, we did not reveal any association between the Per3 
VNTR and both SUD and smoking status. Also, allele frequencies 
were similar in groups.
As far as we know, this is the first study reporting the association 
of Per3 VNTR variant, located in the intron, with the SUD and 
smoking status. Our results suggest the Per3 VNTR variant was 
not associated with SUD and smoking status in a sample from the 
Turkish population. But distribution of variants varies significantly 
among different ethnic groups, this may contribute to the observed 
differences in ethnicity-dependent prevalence. Therefore additional 
studies on larger population will be necessary to confirm our results 
and to provide further insights into cellular clock gene circadian 
mechanism underlying addiction and/or smoking status.
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